Applied-Microbiology Programs

HMI Novel Pathogens Search Research

Novel bacteria of the human microbiota

The HMI has developed innovative approaches that enable the identification of novel, unculturable microbial species within the human microbiota. As a result, the  research of this program is geared towards identifying and characterizing of new, previously uncharacterized human pathogens. The discovery of novel bacteria within the human microbiota will enhance the level of efficacy for the next generation.

Novel bacteria associated with aging

The discovery and characterization of novel microorganisms having a role in longevity will provide new opportunities to postpone ageing.

Novel bacteria associated with  Alzheimer’s disease

The discovery of novel bacteria and viruses playing a role in neurodegeneration will open new opportunities for understanding the pathogenesis of Alzheimer’s, and may contribute to the development of methods for the prevention and treatment of these diseases.

Novel bacteria associated with Parkinson’s disease

The search for previously uncharacterized microorganisms and putative infectious agents that might trigger the onset and progression of Parkinson’s disease will enhance our fundamental understanding of the pathogenesis of Parkinson’s, and may ultimately develop novel methods for the prevention and treatment of this disease.

Novel bacteria associated with autism

Your philanthropy will support our cutting edge researchto evaluatespecific alterations in the microbiota, and the role of such alterations in the development and progression of autism.

Novel bacteria associated with сancer

The Human Microbiology Institute is engaged in innovative efforts to study the specific microbiomes of individuals with different types of cancers. This program helps us to evaluate novel bacteria species that play a crucial role in cancerogenicity and may be involved in oncogenesis.

Novel bacteria associated with age-related infectious diseases

Many infectious diseases in elderly people are caused by previously unknown bacteria. The HMI is applying novel tools to reveal these previously uncharacterized causative agents that would increase the efficacy of treatment of age-related infectious diseases.

Novel bacteria associated with metabolic disorders

The Human Microbiology Institute is dedicated to searching for novel human pathogens, characterizing the role of these organisms in metabolic disorders, and evaluating the particularities of their role in host-microbiota cross-talk, as they pertain to the obesity, Type 1 and 2 diabetes, gout, etc., and develop methods for the prevention and treatment of these diseases.

Novel human pathologies
Microbiota diseases
New group of human viral diseases

The Human Microbiology Institute aims to unmask and characterize the types of diseases that affect and can damage the human microbiota, and to expand our understanding of the role of these diseases and their diagnostic potential in regards to mammalian diseases and lifespan.

Jewish microbiota research

The Human Microbiology Institute is studying particularities of Jewish microbiota in order to reveal its role in some diseases that are more frequently found among the Jewish community. In this research we also elucidate how the microbiota affects the Jewish identity.

Microbiota of Genius’ individuals

The Human Microbiology Institute is performing groundbreaking research into the particularities of the microbiota that affect brain function in a specific manner, leading to high levels of intelligence and/or talent.

NLGE: microbiota regulators

We are performing innovative efforts to reveal the mechanisms by which non-living genetic elements (NLGE), including viruses, cell free DNA and RNA, etc., govern the equilibrium of the microbiota, leading to such diseases as cancers, neurodegenerative disorders, etc.

Donate to Applied-Microbiology Programs